# Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease

> **NCT01753596** · PHASE3 · WITHDRAWN · sponsor: **Medical University of Vienna**

## Conditions studied

- Dry Eye Syndrome

## Interventions

- **DEVICE:** GENTEAL HA® Eye Drops (NOVARTIS, Switzerland)
- **OTHER:** Physiological Sodium Chloride solution (0,9%)

## Key facts

- **NCT ID:** NCT01753596
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-12
- **Primary completion:** 2014-12
- **Final completion:** 2015-02
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2014-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01753596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01753596, "Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01753596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*